🇺🇸 amantadine sulfate in United States

105 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 105

Most-reported reactions

1. General Physical Health Deterioration — 17 reports (16.19%)
2. Death — 13 reports (12.38%)
3. Pyrexia — 13 reports (12.38%)
4. Pneumonia — 11 reports (10.48%)
5. C-Reactive Protein Increased — 10 reports (9.52%)
6. Delirium — 9 reports (8.57%)
7. Dyskinesia — 9 reports (8.57%)
8. Fall — 9 reports (8.57%)
9. Hallucination — 7 reports (6.67%)
10. Tremor — 7 reports (6.67%)

Source database →

Frequently asked questions

Is amantadine sulfate approved in United States?

amantadine sulfate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for amantadine sulfate in United States?

Jee-Young Lee is the originator. The local marketing authorisation holder may differ — check the official source linked above.